13YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
PA-824 | (S)-6,7-二氢-2-硝基-6-[[4-(三氟甲氧基)苯基]甲氧基]-5H-咪唑并[2,1-B][1,3]恶嗪 | 187235-37-6 |
T0901317 | N-(2,2,2-三氟乙基)-N-[4-[2,2,2-三氟-1-羟基-1-(三氟甲基)乙基]苯基]苯磺酰胺 | 293754-55-9 |
KB R7943 mesylate | KB-R7943 甲磺酰酸盐 | 182004-65-5 |
Tebipenem pivoxil | 替比培南;替比培南酯 | 161715-24-8 |
Clopidol | 氯羟吡啶;氯吡多 | 2971-90-6 |
Climbazole | 氯咪巴唑;甘宝素 | 38083-17-9 |
Cabotegravir (GSK744, GSK1265744) | 卡博特韦 | 1051375-10-0 |
ZK756326 | ZK-756326 | 874911-96-3 |
VPS34 inhibitor 1 | VPS34 | 1383716-46-8 |
CX-4945 | CX-4945 | 1009820-21-6 |
LXR-623 (WAY-252623) | 2-[(2-氯-4-氟苯基)甲基]-3-(4-氟苯基)-7-(三氟甲基)-2H-吲唑 | 875787-07-8 |
SR9243 | N-[2-(3-溴苯基)乙基]-2,4,6-三甲基-N-[[3'-(甲基磺酰基)[1,1'-联苯]-4-基]甲基]苯磺酰胺 | 1613028-81-1 |
STF-62247 | N-(3-甲基苯基)-4-(4-吡啶)-2-噻唑胺 | 315702-99-9 |
BTZ043 | BTZ043 (BTZ038, BTZ044) | 957217-65-1 |
RAD51 inhibitor 1 | 3-氯-1-(3,4-二氯苯基)-4-(4-吗啉基)-1H-吡咯-2,5-二酮 | 415713-60-9 |
4μ8C | 4Μ8C | 14003-96-4 |
SRPIN340 | SRPKINHIBITOR | 218156-96-8 |
PTC-209 | PTC-209 | 315704-66-6 |
PFK-015 | PFK-015 | 4382-63-2 |
Tiplaxtinin (PAI-039) | 替普沙汀 | 393105-53-8 |
GSK650394 | 2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 | 890842-28-1 |
4E1RCat | 4E1RCAT | 328998-25-0 |
Rebamipide | 瑞巴派特 | 90098-04-7 |
FPH2 (BRD-9424) | FPH2 | 957485-64-2 |
Nicaraven | 烟拉文 | 79455-30-4 |
Cysteamine Hydrochloride | 半胱胺盐酸盐;beta-巯基乙胺(用于十二指肠溃疡造模) | 156-57-0 |
Picosulfate sodium | 匹可硫酸钠;匹克硫酸钠 | 10040-45-6 |
NDI-091143 | NDI-091143 | 2375840-87-0 |
LB-100 | 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1]HEPTANE-2-CARBOXYLIC ACID | 1026680-07-8 |
Lomitapide | 洛美他派 | 182431-12-5 |
SF1670 | SF1670(PTENINHIBITOR) | 345630-40-2 |
Pentamidine isethionate | 羟乙磺酸喷他脒 | 140-64-7 |
Sal003 | (2E)-3-苯基-N-[2,2,2-三氯-1-[[[(4-氯苯基)氨基]硫代甲酰基]氨基]乙基]-2-丙烯酰胺 | 1164470-53-4 |
CCT007093 | (2E,5E)-2,5-二(2-噻吩基亚甲基)环戊酮 | 176957-55-4 |
Mitoglitazone;CAY10415 | MSDC-0160 | 146062-49-9 |
Tiratricol | 替拉曲可 | 51-24-1 |
(+)-Etomoxir sodium salt | (+)-Etomoxir sodium;R)-(+)-乙莫克舍钠盐 | 828934-41-4 |
EAI045 | EAI-045 | 1942114-09-1 |
Carbimazole | 卡比吗唑 | 22232-54-8 |
2-Nitroimidazole;Azomycin | 2-硝基咪唑 | 527-73-1 |
Etomoxir | 乙莫克舍 | 124083-20-1 |
Enalaprilat Dihydrate | 依那普利拉 | 84680-54-6 |
Perhexiline maleate | 马来酸哌克昔林 | 6724-53-4 |
BAY 41-2272 | BAY 41-2272 | 256376-24-6 |
GW-3965 hydrochloride | 2-[3-[3-[[2-氯-3-(三氟甲基)苄基](2,2-二苯基乙基)氨基]丙氧基]苯基]乙酸盐酸盐 | 405911-17-3 |
Dihydrouracil | 二氢尿嘧啶 | 504-07-4 |
UNC 1999 | UNC1999 | 1431612-23-5 |
Meglumine diatrizoate | 泛影葡胺 | 131-49-7 |
5'-ATP-Na2 | ATP.Na2; 腺苷-5’-三磷酸二钠盐水合物 | 34369-07-8 |
GSK-2879552.2HCl | GSK2879552 | 1902123-72-1 |
Nadifloxacin | 那氟沙星 | 124858-35-1 |
PF06463922 | 劳拉替尼 | 1454846-35-5 |
AC-DEVD-CHO | Ac-DEVD-CHO(Caspase 3抑制剂) | 169332-60-9 |
Larotrectinib | 拉罗替尼 | 1223403-58-4 |
BCECF-AM | 2',7'-二-(2-羧乙基)-5(6)-羧基荧光素乙酰甲酯 | 117464-70-7 |
TEPP-46 | ML-265 | 1221186-53-3 |
5-Ethynyl-2'-deoxyuridine | Edu;5-乙炔基-2'-脱氧尿苷 | 61135-33-9 |
Glucoseoxidase | 葡萄糖氧化酶 | 9001-37-0 |
Nordihydroguaiaretic acid | 去甲二氢愈创木酸 | 500-38-9 |
Fruquintinib(HMPL-013) | 呋喹替尼 | 1194506-26-7 |
GSK4529 | N-(2,6-二氟苯基)-5-[3-[2-[[5-乙基-2-甲氧基-4-[4-[4-(甲基磺酰基)-1-哌嗪基]-1-哌啶基]苯基]氨基]-4-嘧啶基]咪唑并[1,2-A]吡啶-2-基]-2-甲氧基苯甲酰胺 | 1089283-49-7 |
BMS536924,HY-10262, CS-0117 | 胰岛素样生长因子-1 受体拮抗剂 | 468740-43-4 |
NT-157 | NT-157 | 1384426-12-3 |
Clozapine N-oxide | 氯氮平氮氧化合物 | 34233-69-7 |
AP-III-a4 (ENOblock) | AP-III-A4 | 1177827-73-4 |
KN 93 Phosphate | KN-93PHOSPHATE | 1188890-41-6 |
BEC HCl | BEC HCL, 一个竞争性的 ARGINASE II抑制剂 | 222638-67-7 |
AZD3965 | AZD3965 | 1448671-31-5 |
Bromocresol purple | 溴甲酚紫 | 115-40-2 |
FRAX486 | FRAX486 | 1232030-35-1 |
FRAX597 | FRAX597 | 1286739-19-2 |
RSL3 | CS-2409 | 1219810-16-8 |
Leukadherin 1 | 4-(5-((3-苄基-4-氧代-2-硫代噻唑烷-5-亚基)甲基)呋喃-2-基)苯甲酸 | 344897-95-6 |
PF3758309 | PF-3758309 | 898044-15-0 |
CyclicArg-Gly-Asp-D-Tyr-Lys | 环(RGDYK)二三氟醋酸盐 | 250612-42-1 |
MK-801(Dizocilpine)Maleate | (+)-MK 801 顺丁烯二酸盐 | 77086-22-7 |
Talc | 滑石粉(药用级,325目) | 14807-96-6 |
BMS-562086 | 8-(6-甲氧基-2-甲基-3-吡啶基)-2,7-二甲基-N-[(1R)-1-甲基丙基]吡唑并[1,5-A]-1,3,5-三嗪-4-胺 | 459856-18-9 |
Delamanid(OPC-67683) | 迪拉马尼 | 681492-22-8 |
Betrixaban | 贝曲沙班 | 330942-05-7 |
AS1842856 | 5-氨基-7-(环己基氨基)-1-乙基-6-氟-1,4-二氢-4-氧代-3-喹啉羧酸 | 836620-48-5 |
APY29 | APY29 | 1216665-49-4 |
Lificiguat(YC-1) | 利非西呱 | 170632-47-0 |
PF-04449913 | 格拉斯吉布 | 1095173-27-5 |
(±)-Jasmonic acid methyl ester | (±)-茉莉酸甲酯/茉莉酮酸甲酯 | 39924-52-2 |
PEPSIN | 胃蛋白酶(1:3000) | 9001-75-6 |
Deoxyarbutin | 脱氧熊果苷 | 53936-56-4 |
VPS34-IN2 | PIK-III | 1383716-40-2 |
GSK-2292767 | GSK2292767 | 1254036-66-2 |
ADP-Glucose (sodium salt) | ADPG(腺苷-5'-二磷酸葡糖二钠) | 102129-65-7 |
AZD-8835 | AZD-8835 | 1620576-64-8 |
GSK-2269557;GSK 2269557 | CS-2340 | 1254036-71-9 |
MCC950 Sodium (CP-456773) | N-[[(1,2,3,5,6,7-六氢-S-引达省-4-基)氨基]羰基]-4-(1-羟基-1-甲基乙基)-2-呋喃磺酰胺单钠盐 | 256373-96-3 |
ACC;1-Aminocyclopropanecarboxylic acid | ACPC;1-氨基环丙烷羧酸 | 22059-21-8 |
(±)-Jasmonicacid | (±)-茉莉酸 | 77026-92-7 |
NU7441 (KU57788) | 8-(4-二苯并噻吩基)-2-(4-吗啉基)-4H-1-苯并吡喃-4-酮 | 503468-95-9 |
Mdivi1 | Mdivi-1 | 338967-87-6 |
AZD-6738 | AZD6738 | 1352226-88-0 |
Vps34-IN1 | VPS34-IN1 | 1383716-33-3 |
GDC0084 | GDC-0084 | 1382979-44-3 |
联系方式